Velan Capital Investment Management LP

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 1848809 ALPHARETTA, GA

Position in PRAX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$32,470,630

+$2,766,439 QoQ

Shares Held

100,781

0.0% QoQ

Ownership

0.361%

of shares outstanding

% of Portfolio

20.37%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Velan Capital Investment Management LP holds $144,698,271 across 42 Biotechnology names. PRAX ranks #1 (22.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc. This page	100,781	$32,470,630
2	TARA	Protara Therapeutics, Inc.	2,834,652	$14,768,536
3	STRO	Sutro Biopharma, Inc.	512,160	$12,757,905
4	EVMN	Evommune, Inc.	446,255	$10,259,402
5	MPLT	MapLight Therapeutics, Inc.	492,893	$10,020,514
6	TENX	Tenax Therapeutics, Inc.	583,333	$9,327,494
7	ABVX	Abivax S.A.	77,000	$8,573,950
8	HRTX	Heron Therapeutics, Inc. /De/	8,753,290	$7,002,632

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$32,470,630	100,781	0.0%	Shares	Sole	2026-05-15
2025-12-31	$29,704,191	100,781	-24.1%	Shares	Sole	2026-02-13
2025-09-30	$7,038,665	132,805	-11.1%	Shares	Sole	2025-11-14
2025-06-30	$6,279,494	149,334	-19.3%	Shares	Sole	2025-08-14
2025-03-31	$7,005,950	185,000	-38.3%	Shares	Sole	2025-05-15
2024-12-31	$23,088,000	300,000	-14.4%	Shares	Sole	2025-02-14
2024-09-30	$20,177,321	350,666	0.0%	Shares	Sole	2024-11-14
2024-06-30	$14,503,545	350,666	0.0%	Shares	Sole	2024-08-14
2024-03-31	$21,397,639	350,666	+1.4%	Shares	Sole	2024-05-14
2023-12-31	$7,701,438	345,666	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.